About US
Contact us
-
Navidea seeks FDA approval for Lymphoseek injection to detect SLN in cancer patientsNavidea Biopharmaceuticals has filed a supplemental new drug application (sNDA) with the US Food and Drug Administration (FDA) seeking approval for its Lymphoseek injection, designed for the detection2013/12/19
-
Pfizer gives Teva a lift with deal for Viagra generic launch in 2017After years of wrangling over Pfizer's ($PFE) patent onViagra, Teva Pharmaceutical Industries ($TEVA) has made a deal. Under an agreement with Pfizer, the Israeli generics giant can launch its version2013/12/19
-
Biogen Idec and Samsung Bioepis Announce Agreement to Market Anti-TNF Biosimilar Product Candidates in EuropeBiogen Idec and Samsung Bioepishave announced that through their joint venture, Biogen Idec has exercised its right to enter into an agreement to commercialise anti-TNF biosimilar product candidates i2013/12/18
-
NovaBiotics Initiates Development of Orphan Drug in Cystic FibrosisNovaBiotics Ltd, the Aberdeen-based clinical-stage biotechnology company has initiated the development of an inhaled form of Lynovex, its treatment for cystic fibrosis (CF). Lynovex is an orphan dr2013/12/18
-
Recipharm Subsidiary Files Infectious Disease Drug Applicatio​n in European MarketRPH Pharmaceuticals AB, a subsidiary ofRecipharm AB,has filed anapplication for an infectious disease drug product in a range of European countries. The product has been developed through a partnershi2013/12/17
-
Recipharm Subsidiary Files Infectious Disease Drug Applicatio​n in European MarketRPH Pharmaceuticals AB, a subsidiary ofRecipharm AB,has filed anapplication for an infectious disease drug product in a range of European countries. The product has been developed through a partnershi2013/12/17
-
China rounds up counterfeiters as the FDA boosts its oversight thereChinaagreed this month to allow the U.S. FDA to send more people there so it can boost its oversight of Chinese drug production. But as if to prove that it has the situation under control, Chinese aut2013/12/17
-
NIH Network Revolutionises Stroke Clinical ResearchA network of 25 regional stroke centers working with nearby satellite facilities will span the country, have teams of researchers representing every medical specialty needed for stroke care and will a2013/12/16
-
FDA Approves First Generic Versions of Antidepressant Drug CymbaltaFDA hasapproved the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription medicine used to treat depression and other conditions. Aurobindo Pharma Ltd, Dr Reddy’s2013/12/16
-
Roche and Prothena to jointly develop and promote antibodies for Parkinson's treatmentRoche and Prothena have entered into a collaboration to develop and commercialise antibodies that target alpha-synuclein, including PRX002, Prothena's monoclonal antibody for the treatment of Parkinso2013/12/13